A Missed Opportunity: The Ostrich Approach to Indoor Radon Exposure
Small, proactive steps could prevent thousands of radon-related deaths.
The Apple E-Books Litigation: A Page-Turner
Allegations in complaints befit a conspiracy novel – one that Apple argues is completely fictional.
Obama Seeks to Promote “International Regulatory Cooperation”
President issues executive order as way to enhance U.S. economic growth.
In Search of Slowness
Systematic empirical research casts into doubt claims that rulemaking procedures have slowed down the regulatory process.
Do Expert Agencies Outperform Generalist Judges?
Empirical evidence suggests that expert agencies perform no better than courts.
Coalition Calls for Increased Oversight of Synthetic Biology
Advocacy groups say current regulation of synthetic biology offers inadequate public protection.
Nuclear Power After Fukushima
PPR seminar considers how Japan disaster will affect nuclear power globally.
Patents, Patients, and Profits: Winners and Losers in Drug Patent Challenges
Challenges to branded drugs from generic firms have benefits and costs.
Supreme Court and PTO Produce New Rules on “Laws of Nature” Patents
After the Mayo decision, Patent and Trademark Office issues guiding memorandum.
Will Obama be Damaged by New Administrative Scandals?
Recent scandals will likely reinforce existing predispositions more than move the political needle.
Member of Congress Documents “Loophole” for Medical Device Approval
Advocacy groups join Rep. Markey in calling for reform of FDA review process.
